A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

NCT07284511 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Type 1 Diabetes Mellitus
T1D
T1DM
T1DM - Type 1 Diabetes Mellitus

Interventions

DRUG: Tirzepatide
DEVICE: Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM)
BEHAVIORAL: Carbohydrate Counting
BEHAVIORAL: No Meal Announcement

Sponsor

Melissa-Rosina Pasqua

Collaborators

[object Object]
[object Object]
[object Object]